Advancements in artificial intelligence and machine learning are set to revolutionize the diagnosis and prediction of osteoporosis, a prevalent condition that weakens bones and increases fracture risk. A recent systematic review protocol outlines a comprehensive approach to evaluating the effectiveness of these cutting-edge technologies in identifying bone properties associated with osteoporosis.
Comprehensive Evaluation Methods
The study adheres to the PRISMA-P guidelines, ensuring a thorough investigation across multiple databases including PubMed, Embase, and IEEE Xplore up to March 2025. Focusing on adults over 40, the review targets research employing AI and ML techniques to assess bone density and related attributes. Independent reviewers will meticulously screen studies, extract data, and assess bias using tools like RoB 2 and QUADAS-2, guaranteeing the inclusion of only the most relevant and accurate findings.
Transforming Clinical Practices
By comparing AI and ML models with traditional diagnostic methods such as DXA scans, the review aims to highlight significant improvements in detection accuracy and accessibility. The integration of these technologies into clinical settings could lead to more precise osteoporosis screening and management, ultimately reducing the incidence of fractures and improving patient outcomes.
• AI techniques demonstrate superior sensitivity in identifying bone density variations.
• Machine learning models offer enhanced prediction capabilities compared to conventional methods.
• Increased accessibility of AI tools can facilitate widespread osteoporosis screening.
• Potential for personalized treatment plans through detailed bone property analysis.
The findings from this systematic review are poised to influence healthcare professionals, researchers, and policymakers by providing evidence-based insights into the application of AI and ML in bone health assessment. Understanding the strengths and limitations of current studies will aid in developing standardized protocols, ensuring the seamless integration of these technologies into routine clinical practice.
As the healthcare industry continues to embrace digital innovations, the adoption of AI and machine learning for osteoporosis detection represents a significant step forward. These advancements not only promise increased accuracy and efficiency but also hold the potential to make osteoporosis screening more accessible to a broader population, ultimately contributing to better bone health management on a global scale.
By leveraging the power of artificial intelligence, the medical community can enhance early diagnosis and intervention strategies, reducing the burden of osteoporosis-related fractures and improving the quality of life for millions of individuals worldwide.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
